tiprankstipranks
Theseus Pharmaceuticals (THRX)
NASDAQ:THRX
US Market

Theseus Pharmaceuticals (THRX) Stock Investors

63 Followers
Based on 717,103 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold THRX
On average, investors allocate 0.00% of their portfolios to THRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 717,103 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding THRX

11.7%
Last 7
Days
16.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding THRX, out of 717,103 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

THRX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.01%
$3.30
Opened
0.00%
$3.30
Based on the activity of 13,390 investors who made their portfolios public
The table shows changes in THRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

THRX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Marathon Digital Holdings
5.95%
+0.47%
+6.21%
5.10B
Financial
Oracle
4.31%
+0.32%
+1.34%
297.32B
Technology
Micron
5.26%
+0.65%
+4.68%
89.96B
Technology
Marvell
4.72%
+0.49%
+2.49%
56.64B
Technology
Albemarle
4.14%
-0.36%
+0.34%
13.92B
Basic Materials
Merck & Company
4.18%
+0.22%
+3.94%
324.66B
Healthcare
Coherus Biosciences
2.64%
-1.10%
-3.76%
276.18M
Healthcare
Qualcomm
4.75%
-0.08%
+4.69%
169.64B
Technology
Coinbase Global
7.94%
+1.74%
+5.79%
39.35B
Financial
ChargePoint Holdings
3.99%
-0.84%
-1.96%
806.79M
Consumer Cyclical
Based on the activity of 717,103 active portfolios
Open your Smart Portfolio

THRX Investor Analysis

THRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
26.3%
of THRX holders
are under 35
Average Segment Performance
Average P/E Ratio12.71
Beta7.27
Dividend Yield5.47%
THRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.6%
of THRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.96
Beta11.07
Dividend Yield5.92%
THRX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
21.1%
of THRX holders
are over 55
Average Segment Performance
Average P/E Ratio6.89
Beta5.88
Dividend Yield5.37%
Overview of age group and performance of THRX stock investors
See who invests in THRX according to age group and performance.

FAQ

How many retail Investors hold THRX?
<0.1% of TipRanks' retail investors hold THRX in their portfolios.
    What is THRX Investor Sentiment?
    THRX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of THRX in the last 7 days?
      ▼ 11.7% of TipRanks' retail investors changed their holding of THRX in the last 7 days.
        What percentage of retail investors changed their holding of THRX in the last 30 days?
        ▼ 16.0% of TipRanks' retail investors changed their holding of THRX in the last 30 days.
          What is the average age of retail investors who hold THRX?
          The average age of THRX Holders is between 35–55.
            What other stocks have THRX investors also bought?
            THRX Investors also bought MARA, ORCL, MU, MRVL, ALB, MRK, CHRS, QCOM, COIN, CHPT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              CORCencora
              BSXBoston Scientific
              CAHCardinal Health
              CNCCentene
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis